Navigating the Evolving Roles of GLP-1 Agonists Safely and Effectively

Aesthet Surg J. 2024 Oct 15;44(11):1241-1245. doi: 10.1093/asj/sjae166.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy
  • Glucagon-Like Peptide 1* / agonists
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Humans
  • Hypoglycemic Agents* / pharmacology

Substances

  • Glucagon-Like Peptide 1
  • Hypoglycemic Agents
  • Glucagon-Like Peptide-1 Receptor Agonists